-
Product Name
Cevostamab reference antibody
- Documents
-
Description
Anti- FcRH5 / IRTA2 / CD307e Antibody (Cevostamab)
-
Tested applications
ELISA
-
Species reactivity
Human FcRH5 / IRTA2 / CD307e
-
Isotype
IgG1
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
0.1 M Pro-Ac, 20 mM Arg, pH 5.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
SDS-PAGE
Anti- FcRH5 / IRTA2 / CD307e Antibody (cevostamab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
SEC-HPLC
The purity of Anti- FcRH5 / IRTA2 / CD307e Antibody (cevostamab) is 91.59%, determined by SEC-HPLC.
Bioactivity: ELISA
Immobilized human IRTA2 His at 2 ug/mL can bind Anti- FcRH5 / IRTA2 / CD307e Antibody (cevostamab), EC50=0.007032 ug/mL.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"